| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/19/2013 | US20130243852 Adjuvant compositions and methods of potentiating hdac inhibitors used to treat various diseases |
| 09/19/2013 | US20130243842 Compositions and methods for treating bone diseases and broken bones |
| 09/19/2013 | US20130243829 Enhancement of immune response by transfer factor |
| 09/19/2013 | US20130243822 Composition and Method for Healing of Skin Wounds |
| 09/19/2013 | US20130243800 Hla-dr-binding antigen peptide derived from wt1 |
| 09/19/2013 | US20130243797 Composition comprising hydrolysed proteins and oligisaccharides for treating skin diseases |
| 09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
| 09/19/2013 | US20130243794 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses |
| 09/19/2013 | US20130243781 Signal peptide-containing proteins |
| 09/19/2013 | US20130243768 Multimeric proteins and methods of making and using same |
| 09/19/2013 | US20130243765 Chimeric protein |
| 09/19/2013 | US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/19/2013 | US20130243743 Methods and compositions for treating ineffective erythropoiesis |
| 09/19/2013 | US20130243728 Recombinant microorganisms |
| 09/19/2013 | US20130243726 Methods for treating hcv |
| 09/19/2013 | US20130243722 Il-12 for radiation protection and radiation-induced toxicity mitigation |
| 09/19/2013 | US20130243700 Proteomic Antisense Molecular Shield and Targeting |
| 09/19/2013 | US20130243697 Novel Chimeric Proteins and Methods for Using The Same |
| 09/19/2013 | CA2876990A1 Protein to promote blood vessel growth and uses thereof |
| 09/18/2013 | EP2639301A2 Polynucleotides encoding novel PCSK9 variants |
| 09/18/2013 | EP2639241A2 Polypeptides derived from il-2 having agonist activity, for the therapy of cancer and chronic infections |
| 09/18/2013 | EP2638915A1 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
| 09/18/2013 | EP2638073A2 Protein complexes for antigen binding and methods of use |
| 09/18/2013 | EP2638067A2 Subcutaneously administered anti-il-6 receptor antibody |
| 09/18/2013 | EP2638061A1 Soluble pd-1 variants, fusion constructs, and uses thereof |
| 09/18/2013 | EP2638059A1 Dermatopontin-activating peptides and cosmetic compositions including same |
| 09/18/2013 | EP2638058A1 Enolase peptide conjugate vaccines against staphylococcus aureus |
| 09/18/2013 | EP2637684A2 Buffered ophthalmic compositions and methods of use thereof |
| 09/18/2013 | EP2637683A2 Methods for organ regeneration |
| 09/18/2013 | EP2637682A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
| 09/18/2013 | EP2637681A2 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same |
| 09/18/2013 | EP2637680A2 Cancer therapies and diagnostics |
| 09/18/2013 | EP2637679A1 Role of adam10 and its relevance to disease and therapeutics |
| 09/18/2013 | EP2637675A1 Use of interleukin 10 mrna transfected macrophages in anti-inflammatory therapies |
| 09/18/2013 | EP2637663A1 Combination therapy with an antitumor alkaloid |
| 09/18/2013 | EP2637648A1 Pharmaceutical composition, methods for treating and uses thereof |
| 09/18/2013 | CN1897969B Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
| 09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
| 09/18/2013 | CN103314012A Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
| 09/18/2013 | CN103314005A Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions |
| 09/18/2013 | CN103313724A Compounds and methods |
| 09/18/2013 | CN103313723A Peptide |
| 09/18/2013 | CN103305531A Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 09/18/2013 | CN103305494A Antithrombotic enzyme, and preparation method and application thereof |
| 09/18/2013 | CN103304669A Humanization tumor immune cell cytokines TNTIL2 as well as preparation method and application thereof |
| 09/18/2013 | CN103304668A Ultra-VEGF-trap immune fusion protein, its preparation method and application |
| 09/18/2013 | CN103304656A PaaspinosaDavid antibacterial peptide and application thereof |
| 09/18/2013 | CN103304638A PD-L1 affinity peptide with anti-tumour activity and application for same |
| 09/18/2013 | CN103304635A Application of cyclopeptide compound for preventing tumors and preparation method of compound |
| 09/18/2013 | CN103304634A Matrix metalloproteinase-2 polypeptide inhibitor and application |
| 09/18/2013 | CN103304633A Tubulin polymerizing agent polypeptides 1 and application thereof |
| 09/18/2013 | CN103304632A Tubulin polymerizing agent polypeptides 2 and application thereof |
| 09/18/2013 | CN103304631A Nonapeptide with anti-tumour activity |
| 09/18/2013 | CN103304630A GPCR active polypeptide in scorpion venom of Buthus martensii Karsch, and extracting separation and application thereof |
| 09/18/2013 | CN103304628A Nosiheptide derivatives and application thereof |
| 09/18/2013 | CN103301477A Application of escherichia coli succinodehydrogenase iron-sulfur protein SdhB |
| 09/18/2013 | CN103301448A Medicine composition for treating multiple kinds of diarrhea of animals |
| 09/18/2013 | CN103301447A Application of DNA (Deoxyribonucleic Acid)-PKcs in preparation of medicine for changing drug resistance of tumor cells on MTX (Methotrexate) |
| 09/18/2013 | CN103301446A Affinity adsorption material for treating hyperbilirubinemia and preparation method thereof |
| 09/18/2013 | CN103301445A Calcitonin long-acting slow-release microspheres and preparation method and combination thereof |
| 09/18/2013 | CN103301444A New application of recombinant human thymosin alpha collagens |
| 09/18/2013 | CN103301443A Preparation method of stable chicken lyophilized alpha-interferon dosage form |
| 09/18/2013 | CN103301442A Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus |
| 09/18/2013 | CN103301441A Medicine for relieving side effect of normal tissue damage caused by chemotherapy |
| 09/18/2013 | CN103301070A Formulations for a tight junction effector |
| 09/18/2013 | CN103301064A Interleukin-2 or derivative nasal decongestant thereof and preparation method thereof |
| 09/18/2013 | CN103301058A Composition for teriparatide injection, and preparation method and preparation thereof |
| 09/18/2013 | CN102872454B Preparation for relieving piglet stress through drinking water |
| 09/18/2013 | CN102860988B Chymotrypsin composition freeze-dried powder and preparation method thereof |
| 09/18/2013 | CN102727869B Application of soluble interleukin 6 receptor in antiviral medicine preparation |
| 09/18/2013 | CN102676563B Method for preparing human serum albumin-human parathyroid hormone |
| 09/18/2013 | CN102674531B Water-clarifying liver-protecting compound preparation for tilapia aquiculture |
| 09/18/2013 | CN102600453B Preparation method of colistin sulfate premixing agents |
| 09/18/2013 | CN102517387B Application of MVP used as antiviral drug target |
| 09/18/2013 | CN102492043B Anti-tumor and thrombolytic dual-effect chimeric protein with low immunogenicity, its preparation method and application |
| 09/18/2013 | CN102399262B Tripeptides with angiotensin converting enzyme inhibition activity and their use and composition |
| 09/18/2013 | CN102382169B Argatroban single stereoisomer separation method and polymorph |
| 09/18/2013 | CN102370611B Temperature-sensitive hydrogel containing exendin-4 and injection thereof |
| 09/18/2013 | CN102204889B Degarelix acetate lyophilized powder injection and preparation method thereof |
| 09/18/2013 | CN102145163B Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 09/18/2013 | CN102133430B Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 09/18/2013 | CN102079782B Antibacterial peptide used for killing Cryptocaryon irritans and preparation method and applications thereof |
| 09/18/2013 | CN101991557B Liquid vancomycin hydrochloride capsule and preparation method thereof |
| 09/18/2013 | CN101966332B Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell |
| 09/18/2013 | CN101824091B G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof |
| 09/18/2013 | CN101325964B Vip片段和应用方法 Vip fragments and application methods |
| 09/18/2013 | CN101282742B Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 09/18/2013 | CN101269212B Gargle capable of being swallowed |
| 09/18/2013 | CN101228181B Hcv ns3蛋白酶抑制剂 Hcv ns3 protease inhibitors |
| 09/18/2013 | CN101134102B 5T4 antigen-expressed vector |
| 09/17/2013 | US8536315 Production and purification of recombinant arylsulftase |
| 09/17/2013 | US8536314 Fluorescent proteins, their production and use |
| 09/17/2013 | US8536311 Inhibitor protein of the wnt signal pathway |
| 09/17/2013 | US8536307 Anticalins |
| 09/17/2013 | US8536305 Processes for preparing a polypeptide |
| 09/17/2013 | US8536303 Polypeptide inhibitors of HSP27 kinase and uses therefor |
| 09/17/2013 | US8536302 Dockerin polypeptide and method of purifying recombinant fused protein using the same |
| 09/17/2013 | US8536301 Engineered integrin binding peptides |
| 09/17/2013 | US8536231 Methods for treating diabetic foot ulcers |
| 09/17/2013 | US8536225 Therapeutic methods employing nitric oxide precursors |